Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 11 Neoplasms 7 Leukemia, Myeloid, Acute 7 Lung Neoplasms 5 Ovarian Neoplasms 4 Fatigue 4 Colorectal Neoplasms 4 Pancreatic Neoplasms 3 Lymphoma 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Leukemia 2 Hematologic Neoplasms 2 Glioma 2 Genital Neoplasms, Female 2 Esophageal Neoplasms 2 Depression 2 Weight Loss 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Everolimus 17 lutetium Lu 177 dotatate 7 Octreotide 7 pasireotide 6 lanreotide 6 gallium Ga 68 dotatate 5 Temozolomide 5 Sunitinib 5 Positron Emission Tomography Computed Tomography 5 surufatinib 4 pembrolizumab 4 Sorafenib 4 Data Collection 4 Carboplatin 4 3-Iodobenzylguanidine 4 Positron-Emission Tomography 3 Nivolumab 3 Etoposide 3 Capecitabine 3 90Y-octreotide, DOTA-Tyr(3)- 3 pentetreotide 2 pazopanib 2 lenvatinib 2 fosbretabulin 2 fluorodopa F 18 2 cabozantinib 2 avelumab 2 arginyllysine 2 Single Photon Emission Computed Tomography Computed Tomography 2 Pemetrexed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroendocrine Tumors × Palliative Care × Clear all

NCT01849523 2024-05-06

WIN

University Medical Center Groningen

Phase NA Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡